Efficacy and safety of nemolizumab for moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials
Archives of Dermatological Research · 04.07.2026 · 318 (1)
DOI: 10.1007/s00403-026-04692-7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, online erschienen am 04.07.2026. Verfasst von Ling Li und 6 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, L., Yu, J., Huang, D., Zhou, H., Mo, N., Hu, W., & Qian, F. (2026). Efficacy and safety of nemolizumab for moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04692-7
Vancouver
Li L, Yu J, Huang D, Zhou H, Mo N, Hu W, et al. Efficacy and safety of nemolizumab for moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04692-7
BibTeX
@article{Li2026,
author = {Li, Ling and Yu, Jiajun and Huang, Dan and Zhou, Huiwen and Mo, Nian and Hu, Wenting and Qian, Fang},
title = {Efficacy and safety of nemolizumab for moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04692-7}
}
EUVIMED